Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles

Area of Science:

• Mitochondrial biology
• Nanomedicine
• Cancer therapy

Background:

• Mitochondria regulate vital cellular processes like metabolism and cell death.
• let-7b microRNA, a tumor suppressor, targets mitochondrial genes.
• Targeting mitochondria is crucial for novel cancer therapies.

Purpose of the Study:

• To design and evaluate let-7b-loaded nano-carriers for targeted delivery to non-small cell lung cancer (NSCLC) cell mitochondria.
• To investigate the potential of these nano-carriers in inhibiting lung cancer growth.

Main Methods:

• Synthesis of let-7b-PAMAM (G5)-TPP and let-7b-PAMAM (G5)-TPP-HA nano-carriers.
• Utilizing triphenylphosphonium cation (TPP) and hyaluronic acid (HA) for mitochondrial and CD44 receptor targeting, respectively.
• Assessing nano-carrier uptake, mitochondrial localization, cell viability, apoptosis, and gene expression in A549 NSCLC cells.

Main Results:

• Nano-carriers were efficiently internalized by A549 cells and localized within mitochondria.
• let-7b loaded nanoparticles significantly reduced cell viability and induced apoptosis.
• Mitochondrial gene expression related to oxidative function was decreased, demonstrating the nanoparticles' impact on mitochondrial activity.

Conclusions:

• Mitochondria-targeted delivery of let-7b microRNA using novel nano-carriers is a promising strategy for NSCLC inhibition.
• This approach effectively regulates cellular functions within mitochondria to combat lung cancer.
• The developed nano-carriers offer a new avenue for cancer therapy by precisely targeting cancer cell mitochondria.